MAP Sciences

MAP Sciences is a biotechnology company based in Cambridge, UK, specializing in the development of rapid clinical diagnostic tests using MALDI-TOF mass spectrometry. The company's proprietary platform enables high-throughput protein profiling from minimal sample volumes, such as a single drop of blood or urine, to identify specific disease biomarkers. Their primary focus areas include maternal health, specifically screening for pre-eclampsia, as well as the detection of hemoglobinopathies and infectious diseases like COVID-19. By combining advanced mass spectrometry with sophisticated data analytics, MAP Sciences provides cost-effective, accurate, and scalable screening solutions for global healthcare markets. The company collaborates closely with academic and clinical institutions to validate its diagnostic applications and expand its testing menu.